Companies › MYO

MYOMO INC (MYO)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001369290 · EDGAR filings · Updated 2026-07-13

MYOMO INC (MYO) has reported institutional ownership of 33.2%, with 79 institutional managers holding positions valued at $8.65M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings, triggering event that accelerates or increases a direct financial obligation (8-K Item 2.04).

Latest updates

• 2026-07-13 — Insider transaction reported (Form 4)
• 2026-07-13 — Insider transaction reported (Form 4)
• 2026-07-13 — Notice of proposed sale filed (Form 144)
• 2026-06-29 — Amended current report (8-K/A) filed
• 2026-06-26 — Insider transaction reported (Form 4)
• 2026-06-26 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, MYOMO INC has 79 institutional holders and institutional ownership of 33.2%.

Insider activity

Insiders reported 29 transactions (14 buys, 0 sells) across 8 reporting insiders, with a net reported value of $674.9K.

Data flags from SEC filings

Related companies

Entera Bio Ltd (ENTX) · IMMUCELL CORP (ICCC) · METAGENOMI THERAPEUTICS INC (MGX) · Curis Inc (CRIS) · TVARDI THERAPEUTICS INC COM (TVRD) · RENOVORX INC (RNXT)